Status:
ACTIVE_NOT_RECRUITING
Multimodal Therapy Impact on Pancreatic Cancer Survival
Lead Sponsor:
National Cheng Kung University
Conditions:
Pancreatic Cancer
Neoadjuvant Chemotherapy
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this retrospective cohort study is to analyze change of treatment strategies affect the survival outcomes in patients of pancreatic cancer who received curative-intent treatment. The main ...
Detailed Description
This study is to analyze the change of treatment strategies and shift of the paradigm over time in a single center. Researchers plan to see the impact of the evolvement to the survival outcomes in pan...
Eligibility Criteria
Inclusion
- Pancreatic adenocarcinoma
- Received curative surgery
Exclusion
- Other subtypes of pancreatic cancer including acinar cell carcinoma, mucinous carcinoma, undifferentiated carcinoma and intraductal papillary mucinous neoplasm with associated adenocarcinoma
- Cases with palliative or R2 resection were also excluded from the analysis.
Key Trial Info
Start Date :
January 3 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
405 Patients enrolled
Trial Details
Trial ID
NCT06938906
Start Date
January 3 2011
End Date
April 30 2025
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University Hospital
Tainan, Taiwan, 704